Bionexus Gene Lab Corp (BGLC)

Finanzdaten der Bionexus Gene Lab Corp-Aktie (BGLC)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	233.40%0.08	0.02	0.48	2.54	2.26
Cost Of Revenue	167.32%0.06	0.02	0.49	2.17	1.89
Gross Profit	1,743%0.01	-0.00	-0.00	0.38	0.37
	30.30%0.42	0.60	1.05	1.19	1.19
Research and Development	5.63%0.01	0.01	0.01	0.01	0.01
Operating Income/Loss	47.75%-0.28	-0.54	-1.03	-0.70	-0.61
Income/Loss From Continuing Operations Before Tax	47.30%-0.29	-0.54	-1.04	-0.71	-0.62
Income Tax Expense/Benefit, Current	-	-	-	-	-
Income Tax Expense/Benefit, Deferred	-	-	-	-	-
Income Tax Expense/Benefit	-	-	-	-	-
	47.30%-0.29	-0.54	-1.04	-0.71	-0.62
Attributable To Parent	47.30%-0.29	-0.54	-1.04	-0.71	-0.62
Diluted Average Shares	2.42	2.42	-	1.80	1.80
Diluted Earnings Per Share	47.56%-0.12	-0.23	-	-0.40	-0.34